Keine Story von Dafra Pharma mehr verpassen.

Dafra Pharma

16.07.2008 – 13:33

Max Planck Society Awards Exclusive License to Dafra Pharma R&D to Develop a Drug Against Leishmaniasis

Turnhout, Belgium (ots/PRNewswire) - Max Planck Innovation, the technology transfer agency of the Max Planck Society based in Munich, Germany and Dafra Pharma R&D, a Belgian research company belonging to Dafra Pharma International, today signed a license agreement for the development and commercialisation of a ...

mehr

1